| Literature DB >> 28911453 |
Rafidah Ismail1, Hai Yen Lee2, Nor Ainy Mahyudin3, Fatimah Abu Bakar2.
Abstract
In this study, linear relationships between response and concentration were used to estimate the detection limit (DL) and quantification limit (QL) for five avermectins: emamectin, abamectin, doramectin, moxidectin, and ivermectin. Estimation of DL and QL was based on the standard deviation of residual and y-intercept of the regression line at low concentrations of avermectins, using the dispersive solid-phase extraction procedure. Avermectin extracts were analyzed using liquid chromatography tandem mass spectrometry. Based on the regression slope, DL and QL were higher at concentrations of 0.3-0.4 μg/kg and 1 μg/kg, respectively, for all avermectin compounds. Linearity assessment was performed by linear regression, which incorporated a regression model, outlier rejection, and evaluation of the assumption with a significant test. For all avermectins, there is a significant correlation between response and concentration in the range 1-15 μg/kg, and the y-intercept passes through origin (zero).Entities:
Keywords: Avermectins; Detection limit; Dispersive solid-phase extraction; Linear regression; Linearity; Quantification limit
Year: 2014 PMID: 28911453 PMCID: PMC9355011 DOI: 10.1016/j.jfda.2014.01.026
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Regression line parameters for avermectin compounds.
| Compound |
| Slope |
|
| |
|---|---|---|---|---|---|
| EMA | 0.9331 | 3.3008 | −0.6184 | 0.2407 | 0.4051 |
| ABA | 0.9354 | 0.2079 | −0.0352 | 0.0131 | 0.0198 |
| DOR | 0.9407 | 0.3094 | −0.0280 | 0.0187 | 0.0281 |
| MOX | 0.9500 | 0.1897 | −0.0088 | 0.0118 | 0.0199 |
| IVE | 0.9221 | 0.9004 | −0.1888 | 0.0630 | 0.0948 |
ABA = abamectin; DOR = doramectin; EMA = emamectin; IVE = ivermectin; MOX = moxidectin; sres = residual standard deviation of a regression line; syo = standard deviation of y-intercept.
Estimation of DL and QL for avermectins based on linear regression.
| Compound | Estimated DL (μg/kg) | Estimated QL (μg/kg) | ||
|---|---|---|---|---|
|
|
| |||
|
|
|
|
| |
| EMA | 0.22 | 0.40 | 0.73 | 1.23 |
| ABA | 0.19 | 0.31 | 0.63 | 0.95 |
| DOR | 0.18 | 0.30 | 0.60 | 0.91 |
| MOX | 0.19 | 0.35 | 0.62 | 1.05 |
| IVE | 0.21 | 0.35 | 0.70 | 1.05 |
ABA = abamectin; DL = detection limit; DOR = doramectin; EMA = emamectin; IVE = ivermectin; MOX = moxidectin; QL = quantification limit; sres = residual standard deviation of a regression line; syo = standard deviation of y-intercept.
Fig. 1Random scatter of y-residual of avermectins. Symbol ◆ represents response differences, dotted–dashed △ represents −t(0.95, np − 2).sres , and dotted-dashed □ represents −t(0.95, np − 2).sres values.
Confirmation test of linearity for avermectins.
| Sources of variation | Sum of squares | Degrees of freedom | Mean squares | Fisher ratio |
| Conclusion |
|---|---|---|---|---|---|---|
| EMA (1–15 μg/kg) | ||||||
| Regression | 14,358.467 | 1 | 14,358.467 | 314.276 | 4.747 | Regression accepted |
| Lack of fit | 232.250 | 4 | 58.062 | 1.271 | 3.259 | Linearity accepted |
| Pure error | 548.248 | 12 | 45.687 | |||
| Total | 15,138.965 | 17 | ||||
| ABA (1–15 μg/kg) | ||||||
| Regression | 12.285 | 1 | 12.285 | 5133.736 | 4.747 | Regression accepted |
| Lack of fit | 0.028 | 4 | 0.007 | 2.930 | 3.259 | Linearity accepted |
| Pure error | 0.029 | 12 | 0.002 | |||
| Total | 12.342 | 17 | ||||
| DOR (1–15 μg/kg) | ||||||
| Regression | 44.885 | 1 | 44.885 | 4398.502 | 4.747 | Regression accepted |
| Lack of fit | 0.125 | 4 | 0.031 | 3.057 | 3.259 | Linearity accepted |
| Pure error | 0.122 | 12 | 0.010 | |||
| Total | 45.132 | 17 | ||||
| MOX (1–15 μg/kg) | ||||||
| Regression | 23.855 | 1 | 23.855 | 605.673 | 4.747 | Regression accepted |
| Lack of fit | 0.145 | 4 | 0.036 | 0.923 | 3.259 | Linearity accepted |
| Pure error | 0.473 | 12 | 0.039 | |||
| Total | 24.473 | 17 | ||||
| IVE (1–15 μg/kg) | ||||||
| Regression | 286.407 | 1 | 286.407 | 1458.989 | 4.747 | Regression accepted |
| Lack of fit | 0.396 | 4 | 0.099 | 0.504 | 3.259 | Linearity accepted |
| Pure error | 2.356 | 12 | 0.196 | |||
| Total | 289.158 | 17 | ||||
ABA = abamectin; DOR = doramectin; EMA = emamectin; IVE = ivermectin; MOX = moxidectin.
Critical value of F distribution at α = 0.05.
Summary of linear regression of avermectins.
| Compound | Linear range (μg/kg) | Calibration linear equation |
|
|
| Passes through origin |
|---|---|---|---|---|---|---|
| EMA | 1–15 | 0.9484 | 0.482 | 2.776 | Yes | |
| ABA | 1–15 | 0.9954 | 1.905 | 2.776 | Yes | |
| DOR | 1–15 | 0.9945 | 0.975 | 2.776 | Yes | |
| MOX | 1–15 | 0.9747 | 0.041 | 2.776 | Yes | |
| IVE | 1–15 | 0.9905 | 1.197 | 2.776 | Yes |
ABA = abamectin; DOR = doramectin; EMA = emamectin; IVE = ivermectin; MOX = moxidectin.
Critical value at n = 2 degrees of freedom and 95% confidence limit.